Catalys Pacific Fund, Lp - Net Worth and Insider Trading
Catalys Pacific Fund, Lp Net Worth
The estimated net worth of Catalys Pacific Fund, Lp is at least $112 Million dollars as of 2024-05-27. Catalys Pacific Fund, Lp is the 10% Owner of Mineralys Therapeutics Inc and owns about 9,194,579 shares of Mineralys Therapeutics Inc (MLYS) stock worth over $112 Million. Details can be seen in Catalys Pacific Fund, Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Catalys Pacific Fund, Lp has not made any transactions after 2023-02-14 and currently still holds the listed stock(s).
Transaction Summary of Catalys Pacific Fund, Lp
Catalys Pacific Fund, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Catalys Pacific Fund, Lp owns 1 companies in total, including Mineralys Therapeutics Inc (MLYS) .
Click here to see the complete history of Catalys Pacific Fund, Lp’s form 4 insider trades.
Insider Ownership Summary of Catalys Pacific Fund, Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MLYS | Mineralys Therapeutics Inc | 2023-02-14 | 10 percent owner |
Catalys Pacific Fund, Lp Latest Holdings Summary
Catalys Pacific Fund, Lp currently owns a total of 1 stock. Catalys Pacific Fund, Lp owns 9,194,579 shares of Mineralys Therapeutics Inc (MLYS) as of February 14, 2023, with a value of $112 Million.
Latest Holdings of Catalys Pacific Fund, Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics Inc | 2023-02-14 | 9,194,579 | 12.20 | 112,173,864 |
Holding Weightings of Catalys Pacific Fund, Lp
Catalys Pacific Fund, Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Catalys Pacific Fund, Lp has made a total of 1 transactions in Mineralys Therapeutics Inc (MLYS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mineralys Therapeutics Inc is the acquisition of 250,000 shares on February 14, 2023, which cost Catalys Pacific Fund, Lp around $4 Million.
Insider Trading History of Catalys Pacific Fund, Lp
- 1
Catalys Pacific Fund, Lp Trading Performance
GuruFocus tracks the stock performance after each of Catalys Pacific Fund, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Catalys Pacific Fund, Lp is -10.33%. GuruFocus also compares Catalys Pacific Fund, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Catalys Pacific Fund, Lp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Catalys Pacific Fund, Lp's insider trading performs compared to the benchmark.
Performance of Catalys Pacific Fund, Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6 | | | | | |
| Relative Return to S&P 500(%) | -0.76 | | | | | |
Catalys Pacific Fund, Lp Ownership Network
Catalys Pacific Fund, Lp Owned Company Details
What does Mineralys Therapeutics Inc do?
Who are the key executives at Mineralys Therapeutics Inc?
Catalys Pacific Fund, Lp is the 10 percent owner of Mineralys Therapeutics Inc. Other key executives at Mineralys Therapeutics Inc include Chief Medical Officer David Malcom Rodman , director & Chief Executive Officer Jon Congleton , and director & 10 percent owner Ra Capital Healthcare Fund Lp .
Mineralys Therapeutics Inc (MLYS) Insider Trades Summary
Over the past 18 months, Catalys Pacific Fund, Lp made 1 insider transaction in Mineralys Therapeutics Inc (MLYS) with a net purchase of 250,000. Other recent insider transactions involving Mineralys Therapeutics Inc (MLYS) include a net purchase of 10,750 shares made by Jon Congleton , a net sale of 231,816 shares made by David Malcom Rodman , and a net purchase of 1,250,000 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 100 shares of Mineralys Therapeutics Inc (MLYS) in total and bought 0 shares, with a net sale of 100 shares. During the past 18 months, 231,816 shares of Mineralys Therapeutics Inc (MLYS) were sold and 3,322,555 shares were bought by its insiders, resulting in a net purchase of 3,090,739 shares.
Mineralys Therapeutics Inc (MLYS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mineralys Therapeutics Inc Insider Transactions
Catalys Pacific Fund, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Catalys Pacific Fund, Lp. You might contact Catalys Pacific Fund, Lp via mailing address: 301 9-19 Hachiyama, Shibuya, Tokyo M0 150-0035.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
